首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease
【2h】

Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease

机译:淀粉样蛋白多态性构成阿尔茨海默氏病不同病因亚型的构象变异的独特云

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The molecular architecture of amyloids formed in vivo can be interrogated using luminescent conjugated oligothiophenes (LCOs), a unique class of amyloid dyes. When bound to amyloid, LCOs yield fluorescence emission spectra that reflect the 3D structure of the protein aggregates. Given that synthetic amyloid-β peptide (Aβ) has been shown to adopt distinct structural conformations with different biological activities, we asked whether Aβ can assume structurally and functionally distinct conformations within the brain. To this end, we analyzed the LCO-stained cores of β-amyloid plaques in postmortem tissue sections from frontal, temporal, and occipital neocortices in 40 cases of familial Alzheimer’s disease (AD) or sporadic (idiopathic) AD (sAD). The spectral attributes of LCO-bound plaques varied markedly in the brain, but the mean spectral properties of the amyloid cores were generally similar in all three cortical regions of individual patients. Remarkably, the LCO amyloid spectra differed significantly among some of the familial and sAD subtypes, and between typical patients with sAD and those with posterior cortical atrophy AD. Neither the amount of Aβ nor its protease resistance correlated with LCO spectral properties. LCO spectral amyloid phenotypes could be partially conveyed to Aβ plaques induced by experimental transmission in a mouse model. These findings indicate that polymorphic Aβ-amyloid deposits within the brain cluster as clouds of conformational variants in different AD cases. Heterogeneity in the molecular architecture of pathogenic Aβ among individuals and in etiologically distinct subtypes of AD justifies further studies to assess putative links between Aβ conformation and clinical phenotype.
机译:体内形成的淀粉样蛋白的分子结构可以使用发光共轭寡聚噻吩(LCO)(一种独特的淀粉样蛋白染料)进行询问。当与淀粉样蛋白结合时,LCO产生的荧光发射光谱反映了蛋白质聚集体的3D结构。鉴于合成淀粉样β肽(Aβ)已显示出具有不同生物活性的独特结构构象,我们询问Aβ是否可以在大脑中呈现结构和功能上不同的构象。为此,我们分析了40例家族性阿尔茨海默氏病(AD)或偶发性(特发性)AD(sAD)病例的额叶,颞叶和枕叶新皮质的死后组织切片中LCO染色的β-淀粉样斑块的核心。 LCO结合的斑块的光谱属性在大脑中有显着变化,但是淀粉样蛋白核的平均光谱特性在个别患者的所有三个皮质区域中通常相似。值得注意的是,LCO淀粉样蛋白谱在某些家族性和sAD亚型之间以及典型的sAD患者和后皮质萎缩AD患者之间存在显着差异。 Aβ的量及其蛋白酶抗性均与LCO光谱特性不相关。 LCO光谱淀粉样蛋白表型可以部分传递给小鼠模型中实验传播诱导的Aβ斑块。这些发现表明,在不同AD病例中,脑内多态性Aβ-淀粉样蛋白沉积为构象变异的云。个体中病原性Aβ分子结构的异质性以及AD的病因学上不同的亚型证明了进行进一步研究以评估Aβ构象与临床表型之间的假定联系的合理性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号